Adenovirus-Mediated Gene Transfer to Treat Neurologic Disease
Open Access
- 1 August 1998
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 55 (8) , 1061-1064
- https://doi.org/10.1001/archneur.55.8.1061
Abstract
Within the last 10 years the development of tools used to manipulate DNA have shown promise in the generation of a new form of therapeutic intervention known as gene therapy. Gene therapy involves the introduction of genetic material into cells to replace or supplement defective genes or to induce the expression of a novel gene to help alleviate a disease. These manipulations can be done in cells either outside the body and transplanted back in (ex vivo gene therapy) or directly within a specific target organ (in vivo gene therapy). To target and transfer DNA or RNA to cells a variety of techniques have been developed, including the use of replication-defective viruses, lipid bilayers that encapsulate DNA (liposomes), and DNA-coated gold particles that are ballistically shot into cells (gene gun). Most of these topics will be discussed in articles to follow in this series.Keywords
This publication has 7 references indexed in Scilit:
- Long-term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressinNature Medicine, 1997
- Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson diseaseProceedings of the National Academy of Sciences, 1997
- ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsNature Medicine, 1997
- Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factorsNature Medicine, 1997
- Treatment of Advanced CNS Malignancies with the Recombinant Adenovirus H5.010RSVTK: A Phase I Trial. University of Pennsylvania Medical Center, PhiladelphiaHuman Gene Therapy, 1996
- Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcomeBrain Research, 1995
- Manipulation of Adenovirus VectorsPublished by Springer Nature ,1990